Axcella Competitors

Delisted . USA . 
Stock . Axcella Health
AXLADelisted Stock  USD 0.20  0.02  11.11%   
Axcella Health competes with Cyclerion Therapeutics, Kezar Life, CytomX Therapeutics, Assembly Biosciences, and Instil Bio; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Axcella Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Axcella Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Axcella Health competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.200.200.20
Details
Intrinsic
Valuation
LowRealHigh
0.190.190.22
Details

Axcella Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Axcella Health and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Axcella and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Axcella Health does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
CTMX
+ 0.85
PBLA
CFRX
+ 0.59
CYCN
CTMX
+ 0.59
CYCN
NLTX
+ 0.58
PBLA
CTMX
+ 0.56
CFRX
PBLA
+ 0.53
CFRX
  
High negative correlations   
PBLA
- 0.66
KZR
TIL
- 0.64
MGTA
ARDS
- 0.61
CTMX
ARDS
- 0.59
PBLA
NLTX
- 0.56
ARDS
NLTX
- 0.56
KZR

Risk-Adjusted Indicators

There is a big difference between Axcella Stock performing well and Axcella Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Axcella Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CYCN  7.07  0.44  0.02 (0.27) 9.09 
(8.36)
 18.75 
(15.79)
 77.82 
MGTA  2.62  0.06  0.00  0.26  3.40 
(3.33)
 5.88 
(4.29)
 16.99 
KZR  2.97  0.26  0.09  0.37  2.77 
(4.16)
 4.93 
(3.88)
 51.13 
CFRX  5.26 (0.30) 0.00 (1.07) 0.00 
 0.00 
 12.23 
(8.45)
 55.69 
PBLA  7.11 (2.31) 0.00 (8.30) 0.00 
 0.00 
 10.70 
(17.30)
 88.58 
CTMX  2.76 (0.33) 0.00 (0.14) 0.00 
 0.00 
 6.25 
(5.22)
 20.61 
ARDS  7.73  1.22  0.10 (11.63) 7.66 
(12.31)
 12.50 
(12.50)
 140.53 
NLTX  2.25 (0.07) 0.00  0.19  0.00 
 0.00 
 4.05 
(3.53)
 27.84 
ASMB  2.95  0.10  0.00  0.47  4.39 
(2.92)
 8.79 
(5.34)
 21.34 
TIL  9.58  1.71  0.27  0.47  6.82 
(12.82)
 20.63 
(10.89)
 105.83 
All Fundamental Data

Axcella Health Competitive Analysis

The better you understand Axcella Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Axcella Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Axcella Health's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
AXLA CYCN MGTA KZR CFRX PBLA CTMX ARDS NLTX ASMB
 11.11 
 0.20 
Axcella
 1.85 
 2.20 
Cyclerion
 3.80 
 0.82 
Magenta
 0.95 
 7.47 
Kezar
 6.35 
 1.18 
ContraFect
 5.07 
 2.06 
Panbela
 3.92 
 1.06 
CytomX
 8.00 
 0.27 
Aridis
 1.43 
 0.69 
Neoleukin
 1.25 
 17.04 
Assembly
Market Volatility
(90 Days Market Risk)
Very steady
Extremely Dangerous
Very steady
Moderately volatile
Very steady
Very steady
Dangerous
Very steady
Very steady
Relatively risky
Market Performance
(90 Days Performance)
Very Weak
Weak
Very Weak
Modest
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Insignificant
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
High
Dangerous
Below Average
Dangerous
Dangerous
Average
Dangerous
Dangerous
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Over Valued
Under Valued
Over Valued
Over Valued
Under Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Strong Buy
Not Available
Buy
Not Available
Not Available
Buy
Not Available
Not Available
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Not Rated
Hold
Not Rated
Not Rated
Cautious Hold
Not Rated
Not Rated
Strong Sell
Current Ratio
2.69
3.21
10.22
39.64
1.83
0.56
2.05
0.41
12.78
8.31
Net Asset
18.93 M
13.37 M
146.65 M
221.24 M
20.68 M
4.98 M
201.79 M
14.7 M
115.95 M
136.82 M
Profit Margin
N/A
N/A
N/A
N/A
N/A
N/A
0.11
N/A
N/A
-2.12
EBITDA
(67.01 M)
(12.59 M)
(78.98 M)
(99.25 M)
(30.05 M)
(34.76 M)
(4.31 M)
(29.51 M)
(56.48 M)
(64.2 M)
Current Valuation
1.94 M
2.98 M
(32.66 M)
(77.48 M)
(2.32 M)
8.64 M
(27.17 M)
12.11 M
(35.02 M)
13.46 M
Price To Book
8.74
0.71
0.54
0.4
0.44
3.22
5.04
5.4
0.44
4.11
Operating Margin
N/A
N/A
N/A
-14.22
N/A
N/A
0.12
-9.58
N/A
-1.43
Retained Earnings
(418.43 M)
(264.42 M)
(402.03 M)
(350.76 M)
(325.7 M)
(91.09 M)
(723.45 M)
(195.67 M)
(451.06 M)
(785.75 M)
Current Asset
61.65 M
109.19 M
33.34 M
74.47 M
34.1 M
N/A
189.75 M
27.39 M
289 K
68.37 M
Beta
1.01
1.92
2.12
0.22
0.29
0.83
1.06
0.78
1.1
0.59
Number Of Employees
11
1
67
58
23
6
120
37
7
65
Shares Outstanding
2.95 M
2.71 M
60.66 M
7.3 M
10.7 M
3.48 M
78.26 M
36.21 M
2.35 M
6.36 M
Cash Flow From Operations
(69.59 M)
(21.25 M)
(67.09 M)
(81.64 M)
(35.59 M)
(15.28 M)
(56.03 M)
(29.13 M)
(45.61 M)
22.74 M
Total Debt
2.16 M
2.09 M
29.96 M
18.93 M
2.88 M
6.84 M
13.97 M
6.13 M
12.07 M
2.34 M
Return On Equity
-13.7
-1.5
-0.65
-0.51
-6.09
-7.98
-54.75
N/A
-0.38
-1.02
Z Score
-38.64
N/A
-3.88
N/A
-26.92
-49.78
N/A
-26.03
-5.73
N/A
Return On Asset
-0.88
-0.47
-0.29
-0.28
-1.17
-1.92
0.0233
-1.08
-0.19
-0.35
Number Of Shares Shorted
78.18 K
5.5 K
383.03 K
83.71 K
115.97 K
106.97 K
4.44 M
2 M
26.4 K
11.54 K
Book Value Per Share
-0.77
4.56
1.24
25.77
-0.54
-16.57
-0.3
-0.77
34.18
7.5
Current Liabilities
6.16 M
18.4 M
3.39 M
2.18 M
3.77 M
N/A
15.74 M
3.06 M
1.02 M
3.4 M
Total Asset
18.93 M
13.37 M
146.65 M
221.24 M
20.68 M
4.98 M
201.79 M
14.7 M
115.95 M
136.82 M
Debt To Equity
3.02
0.062
0.25
0.045
0.24
N/A
0.67
-0.18
0.11
0.041
Short Ratio
0.75
0.78
1.38
0.93
1.18
0.07
4.41
0.22
1.7
0.41
Target Price
10.62
4.0
1.0
14.5
7.0
410.0
5.29
10.0
1.5
35.5
Shares Owned By Institutions
66.67
40.41
62.63
63.9
6.13
0.59
65.62
11.6
45.58
18.79
Market Capitalization
13.5 M
5.85 M
45.14 M
53.99 M
535.24 K
3.93 M
79.82 M
13.24 M
8.2 M
106.98 M
Price To Earning
-1.1
-0.59
-1.63
-9.34
21.36
N/A
-11.41
-1.41
-4.6
-10.58
Price To Earnings To Growth
N/A
N/A
N/A
N/A
N/A
N/A
-1.8
-0.02
-0.03
N/A
Price To Sales
N/A
27.79
N/A
7.71
N/A
N/A
0.63
7.33
N/A
4.98
Net Income
(81.19 M)
(5.26 M)
(76.46 M)
(101.87 M)
(24.14 M)
(34.93 M)
(569 K)
(30.37 M)
(57.56 M)
(61.23 M)
Earnings Per Share
-18.25
-2.08
-1.11
-13.12
-10.83
-157.02
0.16
-1.15
-12.28
-6.89
Shares Owned By Insiders
15.77
21.9
2.23
14.79
0.65
N/A
1.0
31.53
16.46
31.62
Revenue
N/A
N/A
N/A
7 M
N/A
N/A
101.21 M
N/A
N/A
7.16 M
Working Capital
3.88 M
5.94 M
101.05 M
189.21 M
(3.13 M)
(6.06 M)
27.02 M
(25.27 M)
88.07 M
94.56 M
Cash And Equivalents
44.4 M
30.32 M
128.28 M
306.84 M
27.3 M
2.53 M
194.29 M
6.32 M
116.46 M
116.69 M
Cash Per Share
0.84
0.7
2.13
4.49
0.69
0.12
2.94
0.36
2.73
2.41
Gross Profit
N/A
(29.75 M)
N/A
N/A
(1.61 M)
N/A
53.16 M
(22.61 M)
N/A
(63.9 M)
Day Typical Price
0.19
2.19
0.81
7.42
1.21
2.08
1.05
0.26
0.69
17.03
Accumulation Distribution
0.15
126838.0
0.0482
501.87
0.11
0.0691
29545.31
0.33
0.0563
666.9
Market Facilitation Index
0.03
N/A
0.04
0.0
0.14
0.15
N/A
0.1
0.04
0.0
Daily Balance Of Power
0.6667
0.1333
0.75
0.35
(0.57)
(0.73)
0.5714
0.2
(0.25)
0.42
Period Momentum Indicator
0.02
0.04
0.03
0.07
(0.08)
(0.11)
0.04
0.02
(0.01)
0.21
Rate Of Daily Change
1.11
1.02
1.04
1.01
0.94
0.95
1.04
1.08
0.99
1.01
Day Median Price
0.19
2.18
0.81
7.4
1.22
2.09
1.05
0.25
0.69
17.03
Price Action Indicator
0.025
0.04
0.025
0.1
(0.08)
(0.09)
0.035
0.03
(0.01)
0.11
Coefficient Of Variation
(596.43)
3944.61
2966.12
1593.43
(3,478)
(506.98)
(2,187)
1318.41
(2,179)
2983.73
Mean Deviation
3.96
7.07
2.62
2.97
5.26
7.11
2.76
7.73
2.25
2.95
Jensen Alpha
(0.81)
0.4351
0.064
0.2628
(0.30)
(2.31)
(0.33)
1.22
(0.07)
0.1
Total Risk Alpha
(1.83)
(1.57)
(0.44)
(0.56)
(1.63)
(4.02)
(0.73)
(1.21)
(0.74)
(0.51)
Sortino Ratio
N/A
0.0202
(0.0002)
0.0897
N/A
N/A
N/A
0.104
N/A
0.0038
Downside Variance
N/A
87.76
17.78
8.97
N/A
N/A
N/A
109.52
N/A
20.1
Standard Deviation
5.73
12.42
3.69
6.28
9.01
11.52
3.67
16.01
3.7
4.25
Kurtosis
5.9
9.68
3.46
30.78
13.92
8.2
1.21
34.01
13.95
3.43
Potential Upside
7.69
18.75
5.88
4.93
12.23
10.7
6.25
12.5
4.05
8.79
Treynor Ratio
0.6989
(0.27)
0.2615
0.3657
(1.07)
(8.30)
(0.14)
(11.63)
0.1857
0.4715
Maximum Drawdown
39.29
77.82
16.99
51.13
55.69
88.58
20.61
140.53
27.84
21.34
Variance
32.81
154.3
13.63
39.4
81.14
132.71
13.47
256.26
13.69
18.05
Market Risk Adjusted Performance
0.7089
(0.26)
0.2715
0.3757
(1.06)
(8.29)
(0.13)
(11.62)
0.1957
0.4815
Risk Adjusted Performance
(0.12)
0.0288
0.0338
0.0569
(0.01)
(0.14)
(0.03)
0.0676
(0.03)
0.0339
Skewness
1.23
2.09
(0.42)
4.84
3.17
(1.07)
0.6707
4.94
(2.77)
(0.39)
Semi Deviation
N/A
9.09
3.4
2.77
N/A
N/A
N/A
7.66
N/A
4.39
Information Ratio
(0.19)
0.0153
(0.0002)
0.0428
(0.04)
(0.21)
(0.08)
0.068
(0.08)
0.004
Value At Risk
(9.68)
(15.79)
(4.29)
(3.88)
(8.45)
(17.30)
(5.22)
(12.50)
(3.53)
(5.34)
Expected Short fall
N/A
(8.36)
(3.33)
(4.16)
N/A
N/A
N/A
(12.31)
N/A
(2.92)
Downside Deviation
N/A
9.37
4.22
2.99
N/A
N/A
N/A
10.47
N/A
4.48
Semi Variance
N/A
82.56
11.57
7.69
N/A
N/A
N/A
58.73
N/A
19.29

Axcella Health Competition Performance Charts

Five steps to successful analysis of Axcella Health Competition

Axcella Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Axcella Health in relation to its competition. Axcella Health's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Axcella Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Axcella Health's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Axcella Health, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Axcella Health position

In addition to having Axcella Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Outsourcing Thematic Idea Now

Outsourcing
Outsourcing Theme
Companies involved in providing outsourcing and staffing services to business across different domains. The Outsourcing theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Outsourcing Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Consideration for investing in Axcella Stock

If you are still planning to invest in Axcella Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axcella Health's history and understand the potential risks before investing.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY